Recommendations and Evidence for COVID-19 Vaccine in Patients with Atopic Dermatitis

ZHU Yuyan; YANG Qianwen; HE Xia; HAN Ke; WU Jingxian; XIE Chunbao; LI Suping; SHEN Jincui; LI Wenyuan; WANG Yueyuan; YI Xiaoqing; BIAN Yuan; GOU Mengqiu; ZHU Changyu; TONG Rongsheng

doi:10.14009/j.issn.1672-2124.2022.12.022

您当前的位置：

首页 >

文章列表页 >

Recommendations and Evidence for COVID-19 Vaccine in Patients with Atopic Dermatitis

更新时间：2023-04-16

- Recommendations and Evidence for COVID-19 Vaccine in Patients with Atopic Dermatitis
- Issue 12, Pages: 1526-1529(2022)
- 作者机构：
  
  1. 电子科技大学医学院
  2. 四川省医学科学院·四川省人民医院药学部
  3. 电子科技大学医学院/个体化药物治疗四川省重点实验室
  4. 四川省医学科学院·四川省人民医院检验科
  5. 四川省医学科学院·四川省人民医院神经内科
  6. 成都市第二人民医院皮肤科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2022.12.022
  CLC： R186
- Published：2022，
扫描看全文
ZHU Yuyan, YANG Qianwen, HE Xia, et al. Recommendations and Evidence for COVID-19 Vaccine in Patients with Atopic Dermatitis. [J]. (12):1526-1529(2022)
DOI：

ZHU Yuyan, YANG Qianwen, HE Xia, et al. Recommendations and Evidence for COVID-19 Vaccine in Patients with Atopic Dermatitis. [J]. (12):1526-1529(2022) DOI： 10.14009/j.issn.1672-2124.2022.12.022.

摘要

新型冠状病毒为新型冠状病毒感染的病因，疫苗接种可起到有效的防控作用。然而，部分特定人群尤其是慢性疾病和免疫紊乱的患者，对新型冠状病毒疫苗的接种持观望态度，即疫苗犹豫。特应性皮炎（AD）是一类与免疫紊乱相关的慢性炎症性皮肤病，目前没有明确的指南说明AD患者是否应该接种新型冠状病毒疫苗。本文整理了新型冠状病毒疫苗与AD患者症状间的交集，结合国内外AD患者接种疫苗的相关建议，以及对AD患者接种新型冠状病毒疫苗的回顾性调研，针对AD患者是否应该接种新型冠状病毒疫苗提出建议，旨在为医务工作人员和相关研究人员提供参考。

Abstract

SARS-CoV-2 is responsible for the novel coronavirus infection pandemic

and vaccination is an effective precaution against it. However

due to vaccine hesitancy

certain groups of people

especially those with chronic diseases and immune disorders

are on the fence about novel coronavirus vaccination. Atopic dermatitis（AD） is a chronic inflammatory skin disease associated with immune disorders

and there are no clear guidelines on whether patients with AD should be vaccinated with the COVID-19 vaccine. In this paper

the intersection of COVID-19 vaccine on AD patients’ symptoms will be sorted out

and the issue of whether AD patients should be vaccinated with COVID-19 vaccine will be discussed in combination with the relevant recommendations on AD patients’ vaccination at home and abroad

as well as the retrospective investigation of AD patients’ vaccination with COVID-19 vaccine

to provide a reference for medical staff and relevant researchers.

关键词

新型冠状病毒特应性皮炎新型冠状病毒疫苗疫苗接种

Keywords

SARS-CoV-2Atopic dermatitisCOVID-19 vaccineVaccination

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Recommendations and Evidence for COVID-19 Vaccine in Patients with Systemic Lupus Erythematosus

Progress of Neutralizing Antibodies Against SARS-CoV-2

Systematic Review of Efficacy and Safety of Dupilumab in the Treatment of Adults with Moderate to Severe Atopic Dermatitis

Visualization Analysis of Research Status and Hotspots of Treatment for COVID-19 Based on CiteSpace

Related Author

WU Yue

SHU Yongquan

CUI Xiaojiao

BIAN Yuan

ZHENG Xi

LIU Yilong

CHEN Min

DU Shan

Related Institution

Dept.of Pharmacy, Affiliated Hospital of University of Electronic Science and Technology of China·Sichuan Provincial People’s Hospital

School of Medicine, University of Electronic Science and Technology of China/Sichuan Provincial Key Laboratory of Individualized Drug Therapy

Dept.of Nephrology, Affiliated Hospital of University of Electronic Science and Technology of China·Sichuan Provincial People’s Hospital

Beijing Hospital

Dept.of Dermatology,People’s Hospital of Zhongjiang County

⁰